Scientists at La Jolla Institute for Immunology (LJI) have shed light on how an unusual population of T cells may drive harmful inflammation in people with ulcerative colitis, an autoimmune disease that causes damage to the ...
Jun 19, 2024
0
38
Patients with rheumatoid arthritis (RA) all have a unique and diverse set of antibodies that are involved in the development of the disease. Researchers at Utrecht University unveiled the complexity of these antibodies using ...
May 1, 2024
0
60
Cells within the intestines perform various roles including nutrient absorption, sensing, and maintaining homeostasis. Certain chronic disorders are distinctly characterized by gut inflammation, which disrupts intestinal ...
Apr 2, 2024
0
18
Myotonic dystrophy 2 (DM2) is a form of muscular dystrophy, a disease that leads to progressive muscle degeneration. It is caused by the expansion of a repetitive DNA sequence containing multiple CCTG bases in the CNBP gene. ...
Feb 21, 2024
0
17
Researchers from The Australian National University (ANU) have discovered a previously unknown ability of a group of immune system cells, known as atypical B cells (ABCs), to fight infectious diseases such as malaria.
Feb 8, 2024
0
13
The most common immune cells in our bodies that form the front line in the immune system's defenses against infections are neutrophilic granulocytes. At the same time, neutrophils are also involved in a number of different ...
Jan 31, 2024
0
23
The connection between exercise and inflammation has captivated the imagination of researchers ever since an early 20th-century study showed a spike of white cells in the blood of Boston marathon runners following the race.
Nov 3, 2023
0
161
Researchers from Brigham and Women's Hospital, a founding member of the Mass General Brigham health care system, have designed a probiotic to suppress autoimmunity in the brain, which occurs when the immune system attacks ...
Aug 9, 2023
0
162
An international team of researchers has identified DNA mutations in a gene that senses viral RNA, as a cause of the autoimmune disease lupus, with the finding paving the way for the development of new treatments.
Apr 27, 2022
0
347
A team of researchers at Atara Biotherapeutics has conducted a small Phase I clinical trial of a therapeutic called ATA188 that targets Epstein-Barr infections (EBV) as a treatment for multiple sclerosis (MS). Representatives ...
